| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NRXP | NRX Pharmaceuticals, Inc. | VAN VOORHEES SETH | CHIEF FINANCIAL OFFICER | Dec 16, 2022 | Buy | $1.10 | 30,000 | 33,000 | 46,337 | Dec 19, 2022, 07:09 AM | |
| NRXP | NRX Pharmaceuticals, Inc. | VAN VOORHEES SETH | CHIEF FINANCIAL OFFICER | Nov 25, 2022 | Buy | $1.11 | 16,337 | 18,215 | 16,337 | Dec 19, 2022, 07:08 AM | |
| NRXP | NRX Pharmaceuticals, Inc. | VAN VOORHEES SETH | CHIEF FINANCIAL OFFICER | Nov 25, 2022 | Buy | $1.11 | 16,337 | 18,215 | 16,377 | Nov 28, 2022, 07:42 AM | |
| PDSB | PDS Biotechnology Corp | VAN VOORHEES SETH | Chief Financial Officer | Jun 15, 2021 | Buy | $8.50 | 17,647 | 150,000 | 17,647 | Jun 17, 2021, 06:52 PM | |
| REFR | RESEARCH FRONTIERS INC | VAN VOORHEES SETH | CFO & VP-Business Development | Feb 21, 2020 | Option Exercise | $1.36 | 91,554 | 124,963 | 230,454 | Feb 24, 2020, 04:30 PM | |
| REFR | RESEARCH FRONTIERS INC | VAN VOORHEES SETH | CFO & VP-Buisness Develpoment | Sep 12, 2017 | Buy | $1.15 | 4,000 | 4,600 | 138,900 | Sep 13, 2017, 08:30 AM | |
| REFR | RESEARCH FRONTIERS INC | VAN VOORHEES SETH | CFO & VP-Business Development | Jun 19, 2014 | Buy | $5.45 | 2,000 | 10,900 | 134,900 | Jun 19, 2014, 05:25 PM | |
| REFR | RESEARCH FRONTIERS INC | VAN VOORHEES SETH | VicePresident-Business Dev/CFO | Feb 10, 2011 | Buy | $8.65 | 12,000 | 103,800 | 36,000 | Feb 14, 2011, 07:24 PM | |
| REFR | RESEARCH FRONTIERS INC | VAN VOORHEES SETH | VicePresident-Business Dev/CFO | Feb 10, 2011 | Buy | $8.65 | 12,000 | 103,800 | 12,000 | Feb 14, 2011, 07:24 PM |
Menu